TuHURA Biosciences, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-30.1M | $-21.7M | $-29.3M | $-22.7M | $-38.3M | $-9.1M | $-8.0M | $11.1M |
| Depreciation & Amortization | $71.3K | $116.7K | $177.4K | — | — | — | — | — |
| Depreciation | $71.0K | $117.0K | $177.0K | $60.0K | $30.0K | — | — | — |
| Amortization | — | — | $3.2M | — | $2.0K | $10.0K | $16.3K | $24.5K |
| Stock-Based Compensation | $6.4M | $2.0M | $478.9K | — | — | — | $426.0K | $495.9K |
| Net Cash from Operating Activities | $-27.6M | $-14.7M | $-12.0M | $-20.4M | $-18.9M | $-7.9M | $-6.3M | $-9.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $76.1K | $57.9K | $79.2K | — | — | — | — | — |
| Business Acquisitions | — | — | — | $300.0K | $300.0K | — | — | — |
| Net Cash from Investing Activities | $-1.3M | $-6.1M | $-1.3M | — | $964.0K | — | — | $-12.6K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | $24.8K | — | — | — | — | — |
| Net Cash from Financing Activities | $19.9M | $29.8M | $2.7M | $21.6M | $26.0M | $6.6M | $4.1M | $9.2M |
| Net Change in Cash | $-9.0M | $9.0M | $-10.6M | $1.2M | $8.1M | $-1.3M | $-2.3M | $-614.0K |
| Free Cash Flow | $-27.7M | $-14.8M | $-12.0M | — | — | — | — | — |